Stock screenerAll disclosures →
EDGAR →
SRRK
Conviction 100HealthcareScan · Thu, Jun 25, 2026SRRK$53.84+2.88%
ResistanceSupportVol 14Insider sell4
Vol MA14 1.69M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price53.84
Change+2.88%
Gap-0.01%
Rel volume3.06×
Avg volume1.54M
Avg $ vol74.36M
SMA 2047.01
SMA 5047.68
SMA 20042.50
Price vs 50+12.90%
Price vs 200+26.66%
MA stackbullish
50/200 cross—
Supertrendup · 46.18
RSI (14)70
MACD hist0.98
MACD crossbull · 5d
Stoch %K / %D100 / 94
ADX (14)22
+DI / −DI35 / 12
RSI divergence—
MACD divergence—
ATR %+4.12%
ADR %4.40%
52w high53.84
52w low27.92
From 52w high+0.00%
Above 52w low+92.82%
New 52w highYes
SqueezeOff
Bollinger width24.80%
%B1.09
Donchian pos99.95%
Donchian high53.84
Donchian low43.23
AVWAP (52w high)53.20
vs AVWAP high+1.20%
AVWAP (52w low)44.99
vs AVWAP low+19.66%
OBV trendUp
Chaikin MF (20)0.11
Today vs 20d3.06×
Avg vol (14d)1.69M
Avg vol (20d)1.54M
Avg $ vol (20d)74.36M
Market cap6.45B
RS 3m (vs SPY)+11.45%
RS 6m (vs SPY)+11.47%
RS line new highNo
Trend template8/8
Technical rank85.0
1 week+14.66%
1 month+4.51%
3 months+18.50%
6 months+19.10%
1 year+61.13%
YTD+25.78%
P/E-17.07
P/B23.37
P/S—
P/FCF-21.46
EPS-3.29
Div yield—
ROE-136.93%
ROA-70.61%
Debt/Eq0.71
Current8.64
EV/EBITDA-16.23
Gross margin—
Net margin—
Rev growth-100.00%
EPS growth-53.45%
Price target59.40
Target upside10.34%
Analyst ratingBuy
Institutional117.99%
Ent. value6.22B
Revenue0
Net income-105.51M
Gross profit—
Free cash flow-300.64M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out119.83M
Employees289
ListedThu, May 24, 2018
Free float78.82M
Float %77.3%
Short interest16.43M
Days to cover13.6d
Short volume33.0%
Squeeze score80 / 100
Next earningsWed, Aug 5, 2026 (41d)
EPS forecast−$0.84 · 6 est
Last EPS vs est−$0.83 vs −$0.82
Last surprise-1.2% miss
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank85.0 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance51.79
Support43.26
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in SRRK
No recent disclosed trades by Congress in SRRK. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in SRRK · 9 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Reed Joshua Director · Common Stock · 2026-06-04 | Grant | 6.84K | $0 | 2026-06-04 | 2026-06-08 |
Burow Kristina Director · Stock Option (Right to Buy) · 2026-06-04 | Grant | 4.31K | $0 | 2026-06-04 | 2026-06-08 |
Peng Katie Director · Stock Option (Right to Buy) · 2026-06-04 | Grant | 4.31K | $0 | 2026-06-04 | 2026-06-08 |
AKKARAJU SRINIVAS Director · Common Stock · 2026-06-04 | Other | — | — | 2026-06-04 | 2026-06-08 |
AKKARAJU SRINIVAS Director · Common Stock · 2026-06-04 | Grant | 6.84K | $0 | 2026-06-04 | 2026-06-08 |
Burow Kristina Director · Common Stock · 2026-06-04 | Grant | 6.84K | $0 | 2026-06-04 | 2026-06-08 |
AKKARAJU SRINIVAS Director · Stock Option (Right to Buy) · 2026-06-04 | Grant | 4.31K | $0 | 2026-06-04 | 2026-06-08 |
FLIER JEFFREY S. Director · Stock Option (Right to Buy) · 2026-06-04 | Grant | 4.31K | $0 | 2026-06-04 | 2026-06-08 |
Peng Katie Director · Common Stock · 2026-06-04 | Grant | 6.84K | $0 | 2026-06-04 | 2026-06-08 |
Gilman Michael Director · Stock Option (Right to Buy) · 2026-06-04 | Grant | 4.31K | $0 | 2026-06-04 | 2026-06-08 |
SEC filings
EDGAR filings in SRRK · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.